43 related articles for article (PubMed ID: 24567102)
1. Detection and measurement of paracaspase MALT1 activity.
Hailfinger S; Pelzer C; Thome M
Methods Mol Biol; 2014; 1133():177-88. PubMed ID: 24567102
[TBL] [Abstract][Full Text] [Related]
2. Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
Juilland M; Alouche N; Ubezzi I; Gonzalez M; Rashid HO; Scarpellino L; Erdmann T; Grau M; Lenz G; Luther SA; Thome M
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2301155120. PubMed ID: 38109544
[TBL] [Abstract][Full Text] [Related]
3. MALT1 is not alone after all: identification of novel paracaspases.
Hulpiau P; Driege Y; Staal J; Beyaert R
Cell Mol Life Sci; 2016 Mar; 73(5):1103-16. PubMed ID: 26377317
[TBL] [Abstract][Full Text] [Related]
4. Detection of recombinant and cellular MALT1 paracaspase activity.
Nagel D; Krappmann D
Methods Mol Biol; 2015; 1280():239-46. PubMed ID: 25736752
[TBL] [Abstract][Full Text] [Related]
5. Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase.
Hailfinger S; Lenz G; Thome M
Curr Opin Chem Biol; 2014 Dec; 23():47-55. PubMed ID: 25285878
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.
Jeltsch KM; Hu D; Brenner S; Zöller J; Heinz GA; Nagel D; Vogel KU; Rehage N; Warth SC; Edelmann SL; Gloury R; Martin N; Lohs C; Lech M; Stehklein JE; Geerlof A; Kremmer E; Weber A; Anders HJ; Schmitz I; Schmidt-Supprian M; Fu M; Holtmann H; Krappmann D; Ruland J; Kallies A; Heikenwalder M; Heissmeyer V
Nat Immunol; 2014 Nov; 15(11):1079-89. PubMed ID: 25282160
[TBL] [Abstract][Full Text] [Related]
7. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
[TBL] [Abstract][Full Text] [Related]
9. Probes to monitor activity of the paracaspase MALT1.
Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
[TBL] [Abstract][Full Text] [Related]
10. The paracaspase MALT1: biological function and potential for therapeutic inhibition.
Jaworski M; Thome M
Cell Mol Life Sci; 2016 Feb; 73(3):459-73. PubMed ID: 26507244
[TBL] [Abstract][Full Text] [Related]
11. Activity-based probes for detection of active MALT1 paracaspase in immune cells and lymphomas.
Eitelhuber AC; Vosyka O; Nagel D; Bognar M; Lenze D; Lammens K; Schlauderer F; Hlahla D; Hopfner KP; Lenz G; Hummel M; Verhelst SH; Krappmann D
Chem Biol; 2015 Jan; 22(1):129-38. PubMed ID: 25556945
[TBL] [Abstract][Full Text] [Related]
12. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
[TBL] [Abstract][Full Text] [Related]
13. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
Nie Z; Du MQ; McAllister-Lucas LM; Lucas PC; Bailey NG; Hogaboam CM; Lim MS; Elenitoba-Johnson KS
Nat Commun; 2015 Jan; 6():5908. PubMed ID: 25569716
[TBL] [Abstract][Full Text] [Related]
14. Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation.
Punwani D; Wang H; Chan AY; Cowan MJ; Mallott J; Sunderam U; Mollenauer M; Srinivasan R; Brenner SE; Mulder A; Claas FH; Weiss A; Puck JM
J Clin Immunol; 2015 Feb; 35(2):135-46. PubMed ID: 25627829
[TBL] [Abstract][Full Text] [Related]
15. CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.
Juilland M; Gonzalez M; Erdmann T; Banz Y; Jevnikar Z; Hailfinger S; Tzankov A; Grau M; Lenz G; Novak U; Thome M
Blood; 2016 Apr; 127(14):1780-9. PubMed ID: 26747248
[TBL] [Abstract][Full Text] [Related]
16. MALT1 protease: equilibrating immunity versus tolerance.
Bertossi A; Krappmann D
EMBO J; 2014 Dec; 33(23):2740-2. PubMed ID: 25361604
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
18. GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.
Cheng J; Klei LR; Hubel NE; Zhang M; Schairer R; Maurer LM; Klei HB; Kang H; Concel VJ; Delekta PC; Dang EV; Mintz MA; Baens M; Cyster JG; Parameswaran N; Thome M; Lucas PC; McAllister-Lucas LM
J Clin Invest; 2020 Feb; 130(2):1036-1051. PubMed ID: 31961340
[TBL] [Abstract][Full Text] [Related]
19. Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion.
Xia X; Zhou W; Guo C; Fu Z; Zhu L; Li P; Xu Y; Zheng L; Zhang H; Shan C; Gao Y
Front Oncol; 2018; 8():632. PubMed ID: 30619766
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]